Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study on the Safety and Efficacy of Autologous Immune Cell Therapy for Advanced Solid Tumors

NCT07260058 is registered in ClinicalTrials.gov with Liaoning Medical Diagnosis and Treatment Technology Research and Development Co., Ltd. as lead sponsor.

NCT NCT07260058
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07260058 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study on the Safety and Efficacy of Autologous Immune Cell Therapy for Advanced Solid Tumors
Lead sponsor
Liaoning Medical Diagnosis and Treatment Technology Research and Development Co., Ltd.
Phase
Phase 1/2
Overall status
Not yet recruiting
Start date
December 1, 2025
Completion date
December 31, 2027
Enrollment
48 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

advanced solid tumors, breast cancer (locally advanced or metastatic), colorectal cancer (locally advanced or metastatic), liver cancer (locally advanced or metastatic), lung cancer (locally advanced or metastatic)